Innovation for atrial fibrillation patients
Atrial fibrillation (AF) disease affects 7.8 % of people above 65 years old worldwide, and it is often associated with multimorbidity and polypharmacy. What’s more, AF has a significant economic and societal impact on patients and healthcare systems. As a consequence, there is need for optimised AF disease management. The EU-funded EHRA - PATHS project will create innovative systematic care methods to address multimorbidity in elderly AF patients. The project will further describe multimorbidity, polypharmacy and sex differences using clinical data registries. EHRA - PATHS will also perform European needs assessment research to detect unmet needs and advance new software-supported patient care methods to identify, manage and monitor multimorbidity and polypharmacy in elderly AF patients.
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action
D24 NR0A Dublin
1114 AB Amsterdam-duivendrecht